MedTrace Logo

Initial Experience With the AngioVac Venous Drainage Cannula

NCT02775565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2017-12-08

No results posted yet for this study

Summary

This is a retrospective, record-based study of approximately 100 patients across up to 12 centers within the United States. All patients who have been treated with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit will be considered for study participation. Eligible subject must meet all of the inclusion criteria and none of the exclusion criteria to be considered enrolled in the study. The purpose of the study is to describe initial experience with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit.

Conditions

Interventions

DEVICE

AngioVac

Sponsors & Collaborators

  • Angiodynamics, Inc.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-09-30
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02775565 on ClinicalTrials.gov